HF006
The percentage of patients with a current diagnosis of heart failure due to left ventricular systolic dysfunction, who are currently treated with a beta-blocker licensed for heart failure
| Indicator | Year | Numerator | Denominator | Ratio | Centile |
|---|---|---|---|---|---|
| HF004 | 2019 | 122 | 125 | 97.6% | |
| HF004 | 2020 | 109 | 115 | 94.8% | |
| HF006 | 2021 | 136 | 149 | 91.3% | |
| HF006 | 2022 | 158 | 161 | 98.1% | |
| HF006 | 2023 | 166 | 171 | 97.1% |
